Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Solid Tumors × Infusions, Intravenous × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Melanoma 2 Carcinoma, Non-Small-Cell Lung 2 Solid Tumors 1 Myelodysplastic Syndromes 1 Leukemia, Myeloid, Acute 1 Advanced Malignant Neoplasm 1

Interventions

Paclitaxel 2 Oxaliplatin 2 Leucovorin 2 Irinotecan 2 Fluorouracil 2 Capecitabine 2 nimotuzumab 1 lenvatinib 1 cat's claw extract 1 TH 302 1 Injections 1 Infusions, Intravenous 1 Gemcitabine 1 Drug Evaluation 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05524194 2022-09-01

6MW3511 in Patients With Advanced Solid Tumor

Mabwell (Shanghai) Bioscience Co., Ltd.

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡